Esophageal Neuroendocrine Carcinoma
2 clinical trials · Condition
◉ Watch Esophageal Neuroendocrine Carcinoma
| Record | Firm | Date |
|---|---|---|
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013) | National Cancer Institute (NCI) | 2017-01-30 |
| Octreotide LAR as Maintenance Treatment for Patients With NEC (NCT02409849) | Peking University | 2015-04-01 |
Track Esophageal Neuroendocrine Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.